Editorial
|
| Tumorbinding antibodies and tumor immunity |
|
https://doi.org/10.18632/oncotarget.4889
|
| 35129-35130 |
|
| TLR2 – an innate immune checkpoint in multiple sclerosis |
|
https://doi.org/10.18632/oncotarget.6031
|
| 35131-35132 |
|
| Longistatin in ticksaliva targets RAGE |
|
https://doi.org/10.18632/oncotarget.6032
|
| 35133-35134 |
|
| EPIX4 a novel endogenous antagonist of CXCR4 |
|
https://doi.org/10.18632/oncotarget.6037
|
| 35137-35138 |
|
| AMPK potentiation by LKB1 isoforms |
|
https://doi.org/10.18632/oncotarget.6127
|
| 35139-35140 |
|
| Metabolic plasticity of cancer stem cells |
|
https://doi.org/10.18632/oncotarget.6177
|
| 35141-35142 |
Editorial: Immunology
|
| A framework for T cell assays |
|
https://doi.org/10.18632/oncotarget.6181
|
| 35143-35144 |
Editorial: Autophagy and Cell Death
|
| Metabolism and iron signaling in ferroptotic cell death |
|
https://doi.org/10.18632/oncotarget.5671
|
| 35145-35146 |
|
| Lysosomal mTORC2/PHLPP1/Akt axis: a new point of control of chaperonemediated autophagy |
|
https://doi.org/10.18632/oncotarget.5903
|
| 35147-35148 |
|
| The PHD2 oxygen sensor paves the way to metastasis |
|
https://doi.org/10.18632/oncotarget.6216
|
| 35149-35150 |
Editorial: Chromosome
|
| Epigenetic reprogramming in the mammalian germline |
|
https://doi.org/10.18632/oncotarget.6206
|
| 35151-35152 |
|
| Prmt5 differentiates developmental vs regenerative myogenesis |
|
https://doi.org/10.18632/oncotarget.6207
|
| 35153-35154 |
|
| Coping with cancer genes altered by copy number |
|
https://doi.org/10.18632/oncotarget.6215
|
| 35155-35156 |
Priority Research Papers
|
| Aspirin lysine mifepristone and doxycycline combined can effectively and safely prevent and treat cancer metastasis: prevent seeds from gemmating on soil |
|
https://doi.org/10.18632/oncotarget.6038
|
| 35157-35172 |
|
| PRMT1 promotes mitosis of cancer cells through arginine methylation of INCENP |
|
https://doi.org/10.18632/oncotarget.6050
|
| 35173-35182 |
|
| Epigenetic silencing of miR1455p contributes to brain metastasis |
|
https://doi.org/10.18632/oncotarget.5930
|
| 35183-35201 |
|
| MCL1independent mechanisms of synergy between dual PI3K/mTOR and BCL2 inhibition in diffuse large B cell lymphoma |
|
https://doi.org/10.18632/oncotarget.6051
|
| 35202-35217 |
|
| Chromosome transplantation as a novel approach for correcting complex genomic disorders |
|
https://doi.org/10.18632/oncotarget.6143
|
| 35218-35230 |
|
| The combinatorial activation of the PI3K and Ras/MAPK pathways is sufficient for aggressive tumor formation while individual pathway activation supports cell persistence |
|
https://doi.org/10.18632/oncotarget.6159
|
| 35231-35246 |
|
| Aurora B kinase is a potent and selective target in MYCNdriven neuroblastoma |
|
https://doi.org/10.18632/oncotarget.6208
|
| 35247-35262 |
Research Papers: Gerotarget (Focus on Aging)
|
| RAGE mediated intracellular Aβ uptake contributes to the breakdown of tight junction in retinal pigment epithelium |
|
https://doi.org/10.18632/oncotarget.5894
|
| 35263-35273 |
|
| Rapamycin preserves gut homeostasis during Drosophila aging |
|
https://doi.org/10.18632/oncotarget.5895
|
| 35274-35283 |
|
| Viscoelastic and ultrastructural characteristics of whole blood and plasma in Alzheimertype dementia and the possible role of bacterial lipopolysaccharides LPS |
|
https://doi.org/10.18632/oncotarget.6074
|
| 35284-35303 |
|
| Protease activated receptor1 regulates macrophagemediated cellular senescence: a risk for idiopathic pulmonary fibrosis |
|
https://doi.org/10.18632/oncotarget.6095
|
| 35304-35314 |
|
| IGF1 mediated phosphorylation of specific IRS1 serines in Ames dwarf fibroblasts is associated with longevity |
|
https://doi.org/10.18632/oncotarget.6112
|
| 35315-35323 |
|
| Insights into the role of immunosenescence during varicella zoster virus infection shingles in the aging cell model |
|
https://doi.org/10.18632/oncotarget.6117
|
| 35324-35343 |
|
| Oleuropein aglycone induces autophagy via the AMPK/mTOR signalling pathway: a mechanistic insight |
|
https://doi.org/10.18632/oncotarget.6119
|
| 35344-35357 |
|
| Agedependent uncoupling of mitochondria from Ca2+ release units in skeletal muscle |
|
https://doi.org/10.18632/oncotarget.6139
|
| 35358-35371 |
|
| MiR215p and miR126a3p levels in plasma and circulating angiogenic cells: relationship with type 2 diabetes complications |
|
https://doi.org/10.18632/oncotarget.6164
|
| 35372-35382 |
|
| Moderate exercise training attenuates aginginduced cardiac inflammation hypertrophy and fibrosis injuries of rat hearts |
|
https://doi.org/10.18632/oncotarget.6168
|
| 35383-35394 |
|
| Association between serum uric acid and bone health in general population: a large and multicentre study |
|
https://doi.org/10.18632/oncotarget.6173
|
| 35395-35403 |
|
| cMaf regulates pluripotency genes proliferation/selfrenewal and lineage commitment in ROSmediated senescence of human mesenchymal stem cells |
|
https://doi.org/10.18632/oncotarget.6178
|
| 35404-35418 |
|
| Tumorhost signaling interaction reveals a systemic agedependent splenic immune influence on tumor development |
|
https://doi.org/10.18632/oncotarget.6214
|
| 35419-35432 |
Research Papers: Pathology
|
| Genetic variations of body weight and GCRV resistance in a random mating population of grass carp |
|
https://doi.org/10.18632/oncotarget.5945
|
| 35433-35442 |
|
| Dendritic and Langerhans cells respond to Aβ peptides differently: implication for AD immunotherapy |
|
https://doi.org/10.18632/oncotarget.6123
|
| 35443-35457 |
|
| The ON:OFF switch σ1RHINT1 protein controls GPCRNMDA receptor crossregulation: Implications in neurological disorders |
|
https://doi.org/10.18632/oncotarget.6064
|
| 35458-35477 |
|
| The activation of EGFR promotes myocardial tumor necrosis factorα production and cardiac failure in endotoxemia |
|
https://doi.org/10.18632/oncotarget.6071
|
| 35478-35495 |
|
| Cordycepin prevents oxidative stressinduced inhibition of osteogenesis |
|
https://doi.org/10.18632/oncotarget.6072
|
| 35496-35508 |
Reviews: Gerotarget (Focus on Aging)
|
| DNA damage response DDR and senescence: shuttled inflammamiRNAs on the stage of inflammaging |
|
https://doi.org/10.18632/oncotarget.5899
|
| 35509-35521 |
Reviews
|
| The molecular effect of metastasis suppressors on Src signaling and tumorigenesis: new therapeutic targets |
|
https://doi.org/10.18632/oncotarget.5849
|
| 35522-35541 |
|
| Adaptive responses of androgen receptor signaling in castrationresistant prostate cancer |
|
https://doi.org/10.18632/oncotarget.4689
|
| 35542-35555 |
|
| Leptin signalling obesity and prostate cancer: molecular and clinical perspective on the old dilemma |
|
https://doi.org/10.18632/oncotarget.5574
|
| 35556-35563 |
|
| Free intraperitoneal tumor cells and outcome in gastric cancer patients: a systematic review and metaanalysis |
|
https://doi.org/10.18632/oncotarget.5595
|
| 35564-35578 |
|
| Wnt/βcatenin an oncogenic pathway targeted by H pylori in gastric carcinogenesis |
|
https://doi.org/10.18632/oncotarget.5758
|
| 35579-35588 |
|
| What links BRAF to the heart function new insights from the cardiotoxicity of BRAF inhibitors in cancer treatment |
|
https://doi.org/10.18632/oncotarget.5853
|
| 35589-35601 |
Research Papers
|
| The predictive value of centre tumour CD8+ T cells in patients with hepatocellular carcinoma: comparison with Immunoscore |
|
https://doi.org/10.18632/oncotarget.5801
|
| 35602-35615 |
|
| First description of a sporadic breast cancer in a woman with BRCA1 germline mutation |
|
https://doi.org/10.18632/oncotarget.5348
|
| 35616-35624 |
|
| A newly identified berberine derivative induces cancer cell senescence by stabilizing endogenous Gquadruplexes and sparking a DNA damage response at the telomere region |
|
https://doi.org/10.18632/oncotarget.5521
|
| 35625-35635 |
|
| Retrograde TrkAIII transport from ERGIC to ER: a relocalisation mechanism for oncogenic activity |
|
https://doi.org/10.18632/oncotarget.5802
|
| 35636-35651 |
|
| The novel HSP90 inhibitor AT13387 potentiates radiation effects in squamous cell carcinoma and adenocarcinoma cells |
|
https://doi.org/10.18632/oncotarget.5363
|
| 35652-35666 |
|
| Targeting ERK1/2bim signaling cascades by BH3mimetic ABT737 as an alternative therapeutic strategy for oral cancer |
|
https://doi.org/10.18632/oncotarget.5523
|
| 35667-35683 |
|
| Expression profile of long noncoding RNAs in pancreatic cancer and their clinical significance as biomarkers |
|
https://doi.org/10.18632/oncotarget.5533
|
| 35684-35698 |
|
| The tissue dependent interactions between p53 and Bcl2 in vivo |
|
https://doi.org/10.18632/oncotarget.5372
|
| 35699-35709 |
|
| MiR137 is an androgen regulated repressor of an extended network of transcriptional coregulators |
|
https://doi.org/10.18632/oncotarget.5958
|
| 35710-35725 |
|
| Detection of canonical AtoG editing events at 3’ UTRs and microRNA target sites in human lungs using nextgeneration sequencing |
|
https://doi.org/10.18632/oncotarget.6132
|
| 35726-35736 |
|
| Serine protease inhibitor Kazal type 1 SPINK1 drives proliferation and anoikis resistance in a subset of ovarian cancers |
|
https://doi.org/10.18632/oncotarget.5927
|
| 35737-35754 |
|
| Chemogenetic profiling identifies RAD17 as synthetically lethal with checkpoint kinase inhibition |
|
https://doi.org/10.18632/oncotarget.5928
|
| 35755-35769 |
|
| Natural killer cells facilitate PRAMEspecific Tcell reactivity against neuroblastoma |
|
https://doi.org/10.18632/oncotarget.5657
|
| 35770-35781 |
|
| Bone marrow macrophages support prostate cancer growth in bone |
|
https://doi.org/10.18632/oncotarget.6042
|
| 35782-35796 |
|
| Identification of novel in vivo active Chk1 inhibitors utilizing structure guided drug design |
|
https://doi.org/10.18632/oncotarget.5929
|
| 35797-35812 |
|
| High expression of CTHRC1 promotes EMT of epithelial ovarian cancer EOC and is associated with poor prognosis |
|
https://doi.org/10.18632/oncotarget.5358
|
| 35813-35829 |
|
| Kruppellike factor 2 suppresses mammary carcinoma growth by regulating retinoic acid signaling |
|
https://doi.org/10.18632/oncotarget.5767
|
| 35830-35842 |
|
| Association of glutathione Stransferase T1 and M1 polymorphisms with prostate cancer susceptibility in populations of Asian descent: a metaanalysis |
|
https://doi.org/10.18632/oncotarget.5346
|
| 35843-35850 |
|
| MAGI3 negatively regulates Wnt/βcatenin signaling and suppresses malignant phenotypes of glioma cells |
|
https://doi.org/10.18632/oncotarget.5323
|
| 35851-35865 |
|
| Mechanisms of dihydrotestosterone action on resveratrolinduced antiproliferation in breast cancer cells with different ERα status |
|
https://doi.org/10.18632/oncotarget.5482
|
| 35866-35879 |
|
| Loss of p27Kip1 promotes metaplasia in the pancreas via the regulation of Sox9 expression |
|
https://doi.org/10.18632/oncotarget.5770
|
| 35880-35892 |
|
| The potent tumor suppressor miR497 inhibits cancer phenotypes in nasopharyngeal carcinoma by targeting ANLN and HSPA4L |
|
https://doi.org/10.18632/oncotarget.5651
|
| 35893-35907 |
|
| Blockade of telomerase reverse transcriptase enhances chemosensitivity in head and neck cancers through inhibition of AKT/ERK signaling pathways |
|
https://doi.org/10.18632/oncotarget.5468
|
| 35908-35921 |
|
| Frequent DPH3 promoter mutations in skin cancers |
|
https://doi.org/10.18632/oncotarget.5771
|
| 35922-35930 |
|
| Fendiline inhibits proliferation and invasion of pancreatic cancer cells by interfering with ADAM10 activation and βcatenin signaling |
|
https://doi.org/10.18632/oncotarget.5933
|
| 35931-35948 |
|
| Hippo transducer TAZ promotes epithelial mesenchymal transition and supports pancreatic cancer progression |
|
https://doi.org/10.18632/oncotarget.5772
|
| 35949-35963 |
|
| Dietary NiCl2 causes G2/M cell cycle arrest in the broiler’s kidney |
|
https://doi.org/10.18632/oncotarget.5934
|
| 35964-35977 |
|
| miR573 inhibits prostate cancer metastasis by regulating epithelialmesenchymal transition |
|
https://doi.org/10.18632/oncotarget.5427
|
| 35978-35990 |
|
| Molecular mechanisms underlying the antitumor activity of ENhydroxy314methoxyphenylsulfonyl1234tetrahydroquinolin6ylacrylamide in human colorectal cancer cells in vitro and in vivo |
|
https://doi.org/10.18632/oncotarget.5475
|
| 35991-36002 |
|
| The chimeric antibody chLpMab7 targeting human podoplanin suppresses pulmonary metastasis via ADCC and CDC rather than via its neutralizing activity |
|
https://doi.org/10.18632/oncotarget.5339
|
| 36003-36018 |
|
| Active YAP promotes pancreatic cancer cell motility invasion and tumorigenesis in a mitotic phosphorylationdependent manner through LPAR3 |
|
https://doi.org/10.18632/oncotarget.5935
|
| 36019-36031 |
|
| CD4+ T cells play a crucial role for lenalidomide in vivo antitumor activity in murine multiple myeloma |
|
https://doi.org/10.18632/oncotarget.5506
|
| 36032-36040 |
|
| Targeted massively parallel sequencing of angiosarcomas reveals frequent activation of the mitogen activated protein kinase pathway |
|
https://doi.org/10.18632/oncotarget.5936
|
| 36041-36052 |
|
| Molecular targeting of protein arginine deiminases to suppress colitis and prevent colon cancer |
|
https://doi.org/10.18632/oncotarget.5937
|
| 36053-36062 |
|
| Septin cooperation with tubulin polyglutamylation contributes to cancer cell adaptation to taxanes |
|
https://doi.org/10.18632/oncotarget.5373
|
| 36063-36080 |
|
| Dietary fatty acids intake and endometrial cancer risk: a doseresponse metaanalysis of epidemiological studies |
|
https://doi.org/10.18632/oncotarget.5555
|
| 36081-36097 |
|
| Transgenerational inheritance of enhanced susceptibility to radiationinduced medulloblastoma in newborn Ptch1+/− mice after paternal irradiation |
|
https://doi.org/10.18632/oncotarget.5553
|
| 36098-36112 |
|
| Pharmacological inhibition of BclxL sensitizes osteosarcoma to doxorubicin |
|
https://doi.org/10.18632/oncotarget.5333
|
| 36113-36125 |
|
| The effective bioengineering method of implantation decellularized renal extracellular matrix scaffolds |
|
https://doi.org/10.18632/oncotarget.5304
|
| 36126-36138 |
|
| Sulfonamide derivative targeting carbonic anhydrase IX as a nuclear imaging probe for colorectal cancer detection in vivo |
|
https://doi.org/10.18632/oncotarget.5684
|
| 36139-36155 |
|
| Opposite regulation of MDM2 and MDMX expression in acquisition of mesenchymal phenotype in benign and cancer cells |
|
https://doi.org/10.18632/oncotarget.5392
|
| 36156-36171 |
|
| High glucose uptake unexpectedly is accompanied by high levels of the mitochondrial βF1ATPase subunit in head and neck squamous cell carcinoma |
|
https://doi.org/10.18632/oncotarget.5459
|
| 36172-36184 |
|
| Functional and molecular characterization of cancer stemlike cells in bladder cancer: a potential signature for muscleinvasive tumors |
|
https://doi.org/10.18632/oncotarget.5517
|
| 36185-36201 |
|
| Sensitization of multidrugresistant human cancer cells to Hsp90 inhibitors by downregulation of SIRT1 |
|
https://doi.org/10.18632/oncotarget.5343
|
| 36202-36218 |
|
| HER2 as a novel therapeutic target for cervical cancer |
|
https://doi.org/10.18632/oncotarget.5283
|
| 36219-36230 |
|
| miR25 promotes hepatocellular carcinoma cell growth migration and invasion by inhibiting RhoGDI1 |
|
https://doi.org/10.18632/oncotarget.4740
|
| 36231-36244 |
|
| Axitinib induces DNA damage response leading to senescence mitotic catastrophe and increased NK cell recognition in human renal carcinoma cells |
|
https://doi.org/10.18632/oncotarget.5768
|
| 36245-36259 |
|
| Focused ultrasound enhanced molecular imaging and gene therapy for multifusion reporter gene in gliomabearing rat model |
|
https://doi.org/10.18632/oncotarget.5389
|
| 36260-36268 |
|
| Genetic polymorphisms associated with increased risk of developing chronic myelogenous leukemia |
|
https://doi.org/10.18632/oncotarget.5915
|
| 36269-36277 |
|
| GIT1 promotes lung cancer cell metastasis through modulating Rac1/Cdc42 activity and is associated with poor prognosis |
|
https://doi.org/10.18632/oncotarget.5531
|
| 36278-36291 |
|
| Pharmacologic regulation of AMPK in breast cancer affects cytoskeletal properties involved with microtentacle formation and reattachment |
|
https://doi.org/10.18632/oncotarget.5345
|
| 36292-36307 |
|
| On representing the prognostic value of continuous gene expression biomarkers with the restricted mean survival curve |
|
https://doi.org/10.18632/oncotarget.6121
|
| 36308-36318 |
|
| Inhibition of testicular embryonal carcinoma cell tumorigenicity by peroxisome proliferatoractivated receptorβ/δ and retinoic acid receptordependent mechanisms |
|
https://doi.org/10.18632/oncotarget.5415
|
| 36319-36337 |
|
| Mitochondrial ATF2 translocation contributes to apoptosis induction and BRAF inhibitor resistance in melanoma through the interaction of Bim with VDAC1 |
|
https://doi.org/10.18632/oncotarget.5537
|
| 36338-36353 |
|
| Quinacrine promotes autophagic cell death and chemosensitivity in ovarian cancer and attenuates tumor growth |
|
https://doi.org/10.18632/oncotarget.5632
|
| 36354-36369 |
|
| Regulation of SOX10 stability via ubiquitinationmediated degradation by Fbxw7α modulates melanoma cell migration |
|
https://doi.org/10.18632/oncotarget.5639
|
| 36370-36382 |
|
| SP600125 has a remarkable anticancer potential against undifferentiated thyroid cancer through selective action on ROCK and p53 pathways |
|
https://doi.org/10.18632/oncotarget.5799
|
| 36383-36399 |
|
| mTOR and MEK1/2 inhibition differentially modulate tumor growth and the immune microenvironment in syngeneic models of oral cavity cancer |
|
https://doi.org/10.18632/oncotarget.5063
|
| 36400-36417 |
|
| Phospholipase C gamma 1 PLCG1 R707Q mutation is counterselected under targeted therapy in a patient with hepatic angiosarcoma |
|
https://doi.org/10.18632/oncotarget.5503
|
| 36418-36425 |
|
| Cytoskeletal protein Flightless I inhibits apoptosis enhances tumor cell invasion and promotes cutaneous squamous cell carcinoma progression |
|
https://doi.org/10.18632/oncotarget.5536
|
| 36426-36440 |
|
| Metformin prevents cancer metastasis by inhibiting M2like polarization of tumor associated macrophages |
|
https://doi.org/10.18632/oncotarget.5541
|
| 36441-36455 |
|
| TIC10/ONC201 synergizes with Bcl2/BclxL inhibition in glioblastoma by suppression of Mcl1 and its binding partners in vitro and in vivo |
|
https://doi.org/10.18632/oncotarget.5505
|
| 36456-36471 |
|
| Mitotic entry: Nongenetic heterogeneity exposes the requirement for Plk1 |
|
https://doi.org/10.18632/oncotarget.5507
|
| 36472-36488 |
|
| URGCP promotes nonsmall cell lung cancer invasiveness by activating the NFκBMMP9 pathway |
|
https://doi.org/10.18632/oncotarget.5351
|
| 36489-36504 |
|
| Auranofin induces apoptosis by ROSmediated ER stress and mitochondrial dysfunction and displayed synergistic lethality with piperlongumine in gastric cancer |
|
https://doi.org/10.18632/oncotarget.5364
|
| 36505-36521 |
|
| RD3 loss dictates highrisk aggressive neuroblastoma and poor clinical outcomes |
|
https://doi.org/10.18632/oncotarget.5204
|
| 36522-36534 |
|
| Chitinase 3like 1 induces survival and proliferation of intestinal epithelial cells during chronic inflammation and colitisassociated cancer by regulating S100A9 |
|
https://doi.org/10.18632/oncotarget.5440
|
| 36535-36550 |
|
| Deubiquitinating enzyme USP37 regulating oncogenic function of 1433γ |
|
https://doi.org/10.18632/oncotarget.5336
|
| 36551-36576 |
|
| Good syndrome presenting with CD8+ TCell large granular lymphocyte leukemia |
|
https://doi.org/10.18632/oncotarget.5369
|
| 36577-36586 |
|
| Novel RNA variants in colorectal cancers |
|
https://doi.org/10.18632/oncotarget.5500
|
| 36587-36602 |
|
| Identification of drugs as single agents or in combination to prevent carcinoma dissemination in a microfluidic 3D environment |
|
https://doi.org/10.18632/oncotarget.5464
|
| 36603-36614 |
|
| Overexpression of denticleless E3 ubiquitin protein ligase homolog DTL is related to poor outcome in gastric carcinoma |
|
https://doi.org/10.18632/oncotarget.5620
|
| 36615-36624 |
|
| Application of functional vincristine plus dasatinib liposomes to deletion of vasculogenic mimicry channels in triplenegative breast cancer |
|
https://doi.org/10.18632/oncotarget.5382
|
| 36625-36642 |
|
| Identification of high risk anaplastic gliomas by a diagnostic and prognostic signature derived from mRNA expression profiling |
|
https://doi.org/10.18632/oncotarget.5421
|
| 36643-36651 |
|
| Genome and transcriptome delineation of two major oncogenic pathways governing invasive ductal breast cancer development |
|
https://doi.org/10.18632/oncotarget.5543
|
| 36652-36674 |
|
| microRNA7 as a tumor suppressor and novel therapeutic for adrenocortical carcinoma |
|
https://doi.org/10.18632/oncotarget.5383
|
| 36675-36688 |
|
| PRIMA1met APR246 inhibits growth of colorectal cancer cells with different p53 status through distinct mechanisms |
|
https://doi.org/10.18632/oncotarget.5385
|
| 36689-36699 |
|
| INSM1 increases Nmyc stability and oncogenesis via a positivefeedback loop in neuroblastoma |
|
https://doi.org/10.18632/oncotarget.5485
|
| 36700-36712 |
|
| Hes1 triggers epithelialmesenchymal transition EMTlike cellular marker alterations and promotes invasion and metastasis of nasopharyngeal carcinoma by activating the PTEN/AKT pathway |
|
https://doi.org/10.18632/oncotarget.5457
|
| 36713-36730 |
|
| The axon guidance molecule semaphorin 3F is a negative regulator of tumor progression and proliferation in ileal neuroendocrine tumors |
|
https://doi.org/10.18632/oncotarget.5481
|
| 36731-36745 |
|
| Adiponectin promotes VEGFAdependent angiogenesis in human chondrosarcoma through PI3K Akt mTOR and HIFα pathway |
|
https://doi.org/10.18632/oncotarget.5479
|
| 36746-36761 |
|
| CD44mediated activation of α5β1integrin cortactin and paxillin signaling underpins adhesion of basallike breast cancer cells to endothelium and fibronectinenriched matrices |
|
https://doi.org/10.18632/oncotarget.5461
|
| 36762-36773 |
|
| DAPK loss in colon cancer tumor buds: implications for migration capacity of disseminating tumor cells |
|
https://doi.org/10.18632/oncotarget.4908
|
| 36774-36788 |
|
| Shh and p50/Bcl3 signaling crosstalk drives pathogenesis of BCCs in Gorlin syndrome |
|
https://doi.org/10.18632/oncotarget.5103
|
| 36789-36814 |
Clinical Research Papers
|
| Plasma miR200b in ovarian carcinoma patients: distinct pattern of pre/posttreatment variation compared to CA125 and potential for prediction of progressionfree survival |
|
https://doi.org/10.18632/oncotarget.5766
|
| 36815-36824 |
|
| The timing of surgery after neoadjuvant radiotherapy influences tumor dissemination in a preclinical model |
|
https://doi.org/10.18632/oncotarget.5931
|
| 36825-36837 |
|
| Hepatic resection alone versus in combination with pre and postoperative transarterial chemoembolization for the treatment of hepatocellular carcinoma: A systematic review and metaanalysis |
|
https://doi.org/10.18632/oncotarget.5426
|
| 36838-36859 |
|
| Isolated locoregional recurrence patterns of breast cancer after mastectomy and adjuvant systemic therapies in the contemporary era |
|
https://doi.org/10.18632/oncotarget.5365
|
| 36860-36869 |
|
| Clinicopathological and prognostic factors for longterm survival in Chinese patients with metastatic renal cell carcinoma treated with sorafenib: a singlecenter retrospective study |
|
https://doi.org/10.18632/oncotarget.4874
|
| 36870-36883 |
|
| Risk factors short and long term outcome of anastomotic leaks in rectal cancer |
|
https://doi.org/10.18632/oncotarget.5170
|
| 36884-36893 |
|
| Alterations of biomarker profiles after neoadjuvant chemotherapy in breast cancer: tumor heterogeneity should be taken into consideration |
|
https://doi.org/10.18632/oncotarget.5050
|
| 36894-36902 |
|
| Resected pancreatic ductal adenocarcinomas with recurrence limited in lung have a significantly better prognosis than those with other recurrence patterns |
|
https://doi.org/10.18632/oncotarget.5054
|
| 36903-36910 |
|
| Prognosis of patients with esophageal squamous cell carcinoma after esophagectomy using the log odds of positive lymph nodes |
|
https://doi.org/10.18632/oncotarget.5366
|
| 36911-36922 |
Errata
|
| Erratum: Stromal androgen receptor regulates the composition of the microenvironment to influence prostate cancer outcome |
|
https://doi.org/10.18632/oncotarget.6263
|
| 36923 |
Copyright © 2026 Rapamycin Press LLC dba Impact Journals
Oncotarget ® is a registered trademark of Rapamycin Press LLC
Impact Journals ® is a registered trademark of Rapamycin Press LLC
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLC
